Lip GYH - Search Results

1

'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS).

Torp-Pedersen C, Goette A, Nielsen PB, Potpara T, Fauchier L, John Camm A, Arbelo E, Boriani G, Skjoeth F, Rumsfeld J, Masoudi F, Guo Y, Joung B, Refaat MM, Kim YH, Albert CM, Piccini J, Avezum A, Lip GYH; External Reviewers. Torp-Pedersen C, et al. Among authors: lip gyh. Europace. 2020 May 1;22(5):831-832. doi: 10.1093/europace/euz210. Europace. 2020. PMID: 31725156

2

Fibrinolytic function and atrial fibrillation.

Marín F, Roldán V, Lip GY. Marín F, et al. Thromb Res. 2003 Mar 15;109(5-6):233-40. doi: 10.1016/s0049-3848(03)00259-7. Thromb Res. 2003. PMID: 12818244 Review.

3

Anxiety, depression, and prognosis after myocardial infarction: is there a causal association?

Lane D, Carroll D, Lip GY. Lane D, et al. J Am Coll Cardiol. 2003 Nov 19;42(10):1808-10. doi: 10.1016/j.jacc.2003.08.018. J Am Coll Cardiol. 2003. PMID: 14642692 Free article. No abstract available.

4

Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature.

Roldán V, Marín F, Lip GY, Blann AD. Roldán V, et al. Thromb Haemost. 2003 Dec;90(6):1007-20. doi: 10.1160/TH02-09-0083. Thromb Haemost. 2003. PMID: 14652631 Review.

5

Is depression following acute myocardial infarction an independent risk for mortality?

Lane D, Lip GY, Carroll D. Lane D, et al. Am J Cardiol. 2004 May 15;93(10):1333-4. doi: 10.1016/j.amjcard.2004.01.001. Am J Cardiol. 2004. PMID: 15135723 No abstract available.

6

Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.

Marín F, Corral J, Roldán V, González-Conejero R, del Rey ML, Sogorb F, Lip GY, Vicente V. Marín F, et al. J Mol Cell Cardiol. 2004 Sep;37(3):699-704. doi: 10.1016/j.yjmcc.2004.06.001. J Mol Cell Cardiol. 2004. PMID: 15350843

7

Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment.

Lane D, Lip GY. Lane D, et al. Age Ageing. 2005 Jan;34(1):1-3. doi: 10.1093/ageing/afi008. Age Ageing. 2005. PMID: 15591476 No abstract available.

8

Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation.

Roldán V, Marín F, Martínez JG, García-Herola A, Sogorb F, Lip GY. Roldán V, et al. Am J Cardiol. 2005 Apr 1;95(7):881-2. doi: 10.1016/j.amjcard.2004.12.016. Am J Cardiol. 2005. PMID: 15781023

9

Ethnic differences in cardiovascular and all-cause mortality in Birmingham, England: the Birmingham Factory Screening Project.

Lane DA, Lip GY, Beevers DG. Lane DA, et al. J Hypertens. 2005 Jul;23(7):1347-53. doi: 10.1097/01.hjh.0000173516.60610.b5. J Hypertens. 2005. PMID: 15942456

10

Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation.

Roldán V, Marín F, García-Herola A, Lip GY. Roldán V, et al. Thromb Res. 2005;116(4):321-5. doi: 10.1016/j.thromres.2005.01.005. Epub 2005 Feb 8. Thromb Res. 2005. PMID: 16038717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,609 results

Search Page

Filters